New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 4, 2012
12:20 EDTRGLSRegulus Therapeutics to present new data on miR-21 at Kidney Week
Regulus Therapeutics announced that new preclinical data targeting microRNA-21, miR-21, will be presented at 10:00 a.m. PDT on November 3 in a late-breaking poster session at the American Society of Nephrology's Kidney Week 2012, meeting in San Diego, CA, October 30óNovember 4.
News For RGLS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
10:26 EDTRGLSHigh option volume stocks
Subscribe for More Information
October 29, 2014
15:44 EDTRGLSRegulus Therapeutics price target raised to $23 from $19 at Wedbush
Subscribe for More Information
06:46 EDTRGLSRegulus Therapeutics 5.294M share Secondary priced at $17.00
Subscribe for More Information
October 28, 2014
09:20 EDTRGLSOn The Fly: Pre-market Movers
Subscribe for More Information
October 27, 2014
18:26 EDTRGLSOn The Fly: After Hours Movers
Subscribe for More Information
16:01 EDTRGLSRegulus Therapeutics files to sell $80M of common stock
Subscribe for More Information
October 22, 2014
16:33 EDTRGLSOn The Fly: Closing Wrap
Subscribe for More Information
12:09 EDTRGLSOn The Fly: Midday Wrap
Subscribe for More Information
07:57 EDTRGLSRegulus Therapeutics to host conference call
Conference call to discuss interim results from the ongoing clinical study of RG-101 for treatment of HCV will be held on October 22 at 8:30 am. Webcast Link
07:34 EDTRGLSRegulus Therapeutics' RG-101 for hepatitis C shows positive results
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use